Filter
Sort
Issue 8
Issue 8

In the US, nearly half of all people living with HIV are now aged 50 years or older. Their health care providers face new challenges in managing the e...

Expired: 05.07.2022
Issue 7
Issue 7

Older people living with HIV (PLWH) are a growing population presenting health care providers a unique set of challenges, including accelerated aging,...

Expired: 05.07.2022
Issue 6
Issue 6

In the US, among women at high risk for acquiring HIV infection, only around 2% have initiated PrEP. What are the patient, provider, and system barri...

Expired: 04.02.2022
Issue 5
Issue 5

Worldwide, nearly 38 million people are living with the HIV virus. More than half of these are women. PrEP — HIV pre-exposure prophylaxis &mdash...

Expired: 04.02.2022
Issue 4
Issue 4

People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce t...

Expired: 03.09.2022
Issue 3
Issue 3

People who inject drugs (PWID) account for nearly 10% of new HIV infections. With the rate of injection drug use continuing to rise, the need for effe...

Expired: 03.01.2022
Issue 2
Issue 2

In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns...

Expired: 12.22.2021
Issue 1
Issue 1

The current gold standard for HIV treatment — triple drug therapy — is evolving. Dual drug regimens — two drugs from two separate cl...

Expired: 12.15.2021
Issue 12
Issue 12

“U=U” — an Undetectable HIV viral load means Untransmittable HIV virus. In her recent eHIV Newsletter Issue (Vol. 4; No. 11), Dr. Ji...

Expired: 07.24.2021
Issue 11
Issue 11

U=U: Undetectable = Untransmittable. People with HIV viral loads so low as to be undetectable — are they really no longer able to transmit the v...

Expired: 07.01.2021
Issue 2
Issue 2

PrEP — pre-exposure prophylaxis to prevent HIV transmission — is safe, it’s effective, and it’s significantly underused in the...

Expired: 06.14.2021
Issue 1
Issue 1

Randomized trials have demonstrated that HIV pre-exposure prophylaxis (PrEP) is highly efficacious at preventing HIV acquisition. To date, however, up...

Expired: 06.14.2021
Issue 10
Issue 10

Evidence-based plans to improve adherence — how do they work in practice? How can they most effectively be tailored to each patient’s need...

Expired: 05.30.2021
Issue 9
Issue 9

Many people living with HIV/AIDS (PLWHA) can achieve near-normal life expectancy, suppressed viral load, and lower risk of HIV-related illnesses and c...

Expired: 04.24.2021
Issue 8
Issue 8

While newer antiviral agents like darunavir and the integrase strand transfer inhibitor (INSTI) dolutegravir have shown great efficacy, recent postmar...

Expired: 03.27.2021
Issue 7
Issue 7

Antiretroviral therapy is continually improving, as new agents and combinations of agents become available that decrease the severe morbidity and mort...

Expired: 02.27.2021